Asia Sherman

ClostraBio has translated decades of research into delivering a next-gen probiotic that targets the hundreds of millions of people living with food allergies and sensitivities. Spun out of the University of Chicago, the startup is based on research linking a healthy, butyrate-rich microbiome to food tolerance, and a dysbiotic, low-butyrate microbiome to food allergies. Bioinformatic analysis of food-allergic versus non-allergic microbiomes identified that a single species, Anaerostipes caccae, was enriched in non-allergic individuals and both produced butyrate and showed a strong positive association with intestinal barrier integrity and food tolerance.

At the first East Coast gathering of the SoCal Dietary Supplement Consortium, U.S. Food and Drug Administration officials and industry leaders framed supplement regulation around modernization, risk-based enforcement and practical collaboration.

Holobiome emerged from a growing recognition that the gut microbiome is both profoundly influential and deeply understudied—and that more tools were needed to unlock its vast complexity.

Unilever has announced plans to develop a new global innovation center in New Haven, CT, opening by spring 2029. The multinational consumer goods company says that the $270-million investment reflects its belief in science-led growth and the increasingly central role of the United States in driving innovation across its business.

An investigation into one of aging research’s most closely watched molecules has found that NAD+, a compound central to cellular metabolism, may not decline in human blood the way many researchers once expected. Published in Nature Metabolism, the study reported that whole-blood NAD+ levels remained stable across age groups and lifestyle interventions, challenging the idea that a blood test could use the molecule as a reliable marker of aging.

Ingredient supplier PLT Health Solutions has teamed up with the Alethios decentralized clinical trial platform to provide customers access to faster, scalable clinical research to substantiate competitive science-based claims.

Ingredion Incorporated has added Benicaros, a patented, prebiotic fiber made from upcycled carrot pomace to its portfolio.The acquisition is an asset deal that includes full ownership of all intellectual property, trademarks, human clinical trials and know-how related to manufacturing the product.

Nammex Mushrooms is adding a 100% pure freeze-dried lion’s mane mycelium powder standardized to 1% of neuroactive compound erinacine A to its portfolio of functional mushroom extracts. It is the company’s first official foray into mycelium, the vegetative, root-like network of thin thread-like hyphae strands responsible for absorbing nutrients and connecting the entire fungal network.

Emerging clinical evidence continues to strengthen the case for krill oil as a differentiated omega-3 delivery format, with a recently published study suggesting it may raise circulating EPA and DHA more effectively than conventional fish oil even when the dose is matched.

Pet supplement science is widening well beyond traditional multivitamins, with new studies spotlighting a more diverse ingredient mix that includes postbiotics, host-adapted microbial strains, plant extracts, beta-glucans and specialty compounds such as palmitoylethanolamide.